Newly private ERT to buy invivodata for ePRO boost
eResearch Technologies (ERT) says it will buy invivodata citing the electronic patient reported outcomes (ePRO) market as the key driver for the deal.
Archives for July 8, 2012
Less regulatory pressures, more growth: say top pharma execs
Pharma execs are now spending as much time dealing with increasing levels of regulations as they spend on growing their businesses, according to KPMG.
iGATE says new data management tech will change R&D
iGATE says its new information management platform will provide a 70 per cent decrease in content management costs for the drug development process.
Lipotec pharma units not included in Lubrizol takeover
The takeover of peptide-based actives developer Lipotec by industrial chemicals firm Lubrizol will not include the Spanish firm’s pharma business.
News from the EMA, Cipla, and MethylGene – People on the move
in-PharmaTechnologist.com presents its weekly round-up of the latest chops and changes in the pharmaceutical industry, including news from the EMA, Cipla, and MethylGene.
No cuts at DPT Labs says new owner Renaissance Pharma
No job losses, facility divestitures or strategic changes are planned at DPT Laboratories according to new owner Renaissance Pharma, which bought the CDMO in an out-of-the-blue deal last week.